Banxia Xiexin Decoction Is Effective to Prevent and Control Irinotecan-Induced Delayed Diarrhea in Recurrent Small Cell Lung Cancer

Background: Irinotecan (CPT-11) can be used as a first-line therapeutic drug against extensive-stage small cell lung cancer (SCLC); it can also be used in second-line treatment for SCLC. CPT-11-induced delayed diarrhea restricts its clinical application. This study aimed to confirm whether Banxia Xi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Hongyang, Qin, Jing, Han, Na, Xie, Fajun, Gong, Lei, Li, Chenghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247536/
https://www.ncbi.nlm.nih.gov/pubmed/30229683
http://dx.doi.org/10.1177/1534735418801532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247536/
https://www.ncbi.nlm.nih.gov/pubmed/30229683
http://dx.doi.org/10.1177/1534735418801532

Ejemplares similares